Singh RB, Gupta UC, Mittal N, Niaz MA, Ghosh S, Rastogi V
For those finding it challenging to choose the most suitable option, it is advisable to seek professional guidance
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
It wont pass the Senate, but in general, we should take a long hard look in the mirror about cutting Medicaid, which supports quite a few vulnerable populations